𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of Support with EPO and GCSF on Outcome of Antiviral Therapy in Treatment-Naive Chronic Hepatitis C Patients from Northern India

✍ Scribed by Saraswat, Vivek; Morakhia, Nakul; Pandey, Gaurav; Venugopal, Sreejith; Mohindra, Samir

Book ID
122293091
Publisher
Elsevier
Year
2014
Tongue
English
Weight
63 KB
Volume
4
Category
Article
ISSN
0973-6883

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of disease severity on outcome of
Impact of disease severity on outcome of antiviral therapy in treatment-naΓ―ve patients with chronic hepatitis C
✍ Johan Westin; Kristoffer Hellstrand; Γ…sa AlsiΓΆ; Magdalena Ydreborg; Carlo Ferrar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

The results encourage a new HDV classification in which the Deltavirus genus consists of 8 major clades, 5 of them being present in Africa (i.e., clade 1, 5, 6, 7, and 8). 7 Interestingly, clade 5 isolates represent approximately 20% of HDV RNA-positive samples, which is stable for the time period i

Impact of diabetes mellitus on incidence
Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy
✍ Chao-Hung Hung; Chuan-Mo Lee; Jing-Houng Wang; Tsung-Hui Hu; Chien-Hung Chen; Ch πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 644 KB

## Abstract There is strong evidence linking chronic hepatitis C virus (HCV) infection and Type 2 diabetes mellitus (DM). Recent studies have suggested that DM is associated with increased risk of developing hepatocellular carcinoma (HCC). The aim of our cohort study was to assess whether DM influe

Impact of IL28B on treatment outcome in
Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin
✍ Thomas-Matthias Scherzer; Albert Friedrich StΓ€ttermayer; Michael Strasser; Herma πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 502 KB

The IL28B genotype is the most important pretreatment predictor of treatment outcome in patients with chronic hepatitis C. The impact of the rs12979860 genotype on relapse was retrospectively evaluated in genotype 1/4 patients who received response-guided therapy with peginterferon alpha-2a 180 ΞΌg/w